Clinical Trial Update: Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing intravenous almitrine to reduce mechanical ventilation needs in hypoxemic respiratory failure from Covid-19 pneumonia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Hypoxemic Respiratory Failure

Drugs mentioned

• Almitrine (almitrine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Covid 19, Hypoxemic Respiratory Failure | Phase 3 | Status: COMPLETED